McCormick Q2 Earnings Preview: Key Estimates and Trends
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1 hour ago
0mins
Source: seekingalpha
- Earnings Announcement Date: McCormick (MKC) is set to release its Q2 earnings on June 25th after market close, with consensus EPS estimated at $0.70, reflecting a modest 1.4% year-over-year growth, indicating the company's efforts to maintain stable profitability.
- Revenue Expectations: The anticipated revenue of $1.91 billion for Q2 represents a 15.1% year-over-year increase, showcasing McCormick's positive performance in market demand growth and product portfolio optimization, which could drive future market share gains.
- Historical Performance: Over the past two years, McCormick has beaten EPS and revenue estimates 75% of the time, demonstrating strong financial management and market adaptability, which enhances investor confidence.
- Estimate Revision Trends: Despite experiencing 8 downward revisions and 7 downward revisions for revenue estimates in the last three months, with no upward revisions, this cautious market sentiment may impact short-term stock price volatility.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy MKC?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on MKC
Wall Street analysts forecast MKC stock price to rise
3 Analyst Rating
3 Buy
0 Hold
0 Sell
Strong Buy
Current: 47.380
Low
75.00
Averages
83.67
High
89.00
Current: 47.380
Low
75.00
Averages
83.67
High
89.00
About MKC
McCormick & Company, Incorporated manufactures, markets, and distributes herbs, spices, seasonings, condiments and flavors to the entire food and beverage industry, including retailers, food manufacturers and foodservice businesses. It operates through two segments: consumer and flavor solutions. The consumer segment sells to retail channels, including grocery, mass merchandise, warehouse clubs, discount and drug stores, and e-commerce under the McCormick brand and a variety of brands around the world, including French's, Frank's RedHot, Lawry’s, Zatarain’s, Simply Asia, Thai Kitchen, Ducros, Vahine, Cholula, Schwartz, Club House, Kamis, DaQiao, La Drogheria, Stubb's, OLD BAY, Gourmet Garden, and others. In its flavor solutions segment, it provides a range of products to multinational food manufacturers and foodservice customers. The foodservice customers are supplied with branded, packaged products both directly by the Company and indirectly through distributors.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Earnings Announcement Date: McCormick (MKC) is set to release its Q2 earnings on June 25th after market close, with consensus EPS estimated at $0.70, reflecting a modest 1.4% year-over-year growth, indicating the company's efforts to maintain stable profitability.
- Revenue Expectations: The anticipated revenue of $1.91 billion for Q2 represents a 15.1% year-over-year increase, showcasing McCormick's positive performance in market demand growth and product portfolio optimization, which could drive future market share gains.
- Historical Performance: Over the past two years, McCormick has beaten EPS and revenue estimates 75% of the time, demonstrating strong financial management and market adaptability, which enhances investor confidence.
- Estimate Revision Trends: Despite experiencing 8 downward revisions and 7 downward revisions for revenue estimates in the last three months, with no upward revisions, this cautious market sentiment may impact short-term stock price volatility.
See More
- Glacier Bancorp Dividend: On June 23, 2026, Glacier Bancorp's Board declared a quarterly dividend of $0.33 per share, marking its 165th consecutive dividend and 49 increases, demonstrating its strong profitability and commitment to shareholder returns.
- McCormick Dividend: McCormick announced a quarterly dividend of $0.48 per share, payable on July 20, 2026, to shareholders of record on July 6, reflecting its 102 years of consecutive dividend payments, showcasing long-term financial health and stability.
- CMC Dividend: CMC declared a quarterly cash dividend of $0.20 per share on June 24, 2026, with its 247th consecutive dividend to be paid on July 15, indicating the company's ongoing commitment to shareholder returns and stable cash flow.
- Millrose Properties Dividend: Millrose Properties announced a quarterly cash dividend of approximately $127.9 million, or $0.77 per share, payable on July 15, 2026, reflecting the company's strong performance in the residential market and its ability to return value to shareholders.
See More
- Market Volatility: The S&P 500 index attempted a 0.86% recovery after two days of losses but ultimately reversed course, indicating fragile market sentiment that investors should navigate cautiously.
- Oil Price Impact: U.S. benchmark WTI crude briefly dipped below $70 per barrel, and while the decline in energy prices eased inflation concerns, the market's response remained weak, failing to provide a significant boost to stocks.
- Linde Stock Surge: Citi raised Linde's price target from $585 to $600, anticipating strong growth in North American manufacturing and electronics, with shares up over 21% year-to-date, outperforming the S&P 500.
- Micron Earnings Anticipation: Micron is set to release its earnings report, with the market eagerly awaiting insights on supply and demand dynamics for high bandwidth memory, especially after a remarkable 250% stock price increase this year, leading analysts to maintain a positive outlook.
See More
- Dividend Declaration: McCormick's Board of Directors has declared a quarterly dividend of $0.48 per share, payable on July 20, 2026, to shareholders of record on July 6, 2026, reflecting the company's ongoing financial stability and commitment to shareholders.
- Consecutive Payment Record: This marks the 102nd consecutive year of dividend payments, demonstrating McCormick's long-term commitment to shareholder returns, which enhances investor confidence and may attract more long-term investors.
- Global Market Leadership: With approximately $7 billion in annual sales across 150 countries and territories, McCormick's position as a global leader in flavor allows it to meet consumer demand for flavor, driving sustainable growth.
- Business Strategy: The company leverages synergies between its Consumer and Flavor Solutions segments, utilizing scale, insights, and technology to drive sustainable growth, further solidifying its market position in the food and beverage industry.
See More
- Quarterly Dividend Announcement: McCormick's Board of Directors declared a quarterly dividend of $0.48 per share, payable on July 20, 2026, to shareholders of record on July 6, marking the company's 102nd consecutive year of dividend payments, reflecting its stable financial performance and commitment to shareholders.
- Global Sales Scale: With approximately $7 billion in annual sales across 150 countries and territories, McCormick's extensive portfolio of herbs, spices, and seasonings underscores its leadership in the global food and beverage industry, catering to the growing consumer demand for flavor.
- Brand Diversity: The company boasts a range of well-known brands, including McCormick, French's, and Frank's RedHot, which enhances its competitive edge in the market and strengthens customer loyalty through a rich product offering.
- Sustainable Growth Strategy: By leveraging synergies between its Consumer and Flavor Solutions segments, McCormick utilizes scale, insights, and technology to drive sustainable growth, ensuring it remains competitive in the evolving market landscape.
See More
- Acquisition Bid: AbbVie is planning to acquire Apogee Therapeutics for approximately $10.9 billion, a price that is about 60% higher than Thursday's closing price, which could significantly enhance AbbVie's market share in the dermatology treatment sector.
- Market Reaction: Apogee's stock surged over 50% in pre-market trading, reflecting a positive market response to the deal, while AbbVie's stock remained relatively unchanged, indicating investor confidence in its long-term strategy.
- Drug Potential: Apogee's new drug, Zumilokibart, is expected to enter Phase 3 trials later this year, and if approved, it will compete against Regeneron's Dupixent, which generated $17.8 billion in revenue last year, showcasing the market potential of Apogee's drug.
- Industry Outlook: AbbVie's acquisition not only diversifies its product pipeline but also strengthens its competitive position in the rapidly evolving dermatology market by potentially integrating Apogee's innovative therapies, thereby solidifying its leadership in the industry.
See More











